Skip to content

Value of TRIM7 in assessing the severity of the condition and determining prognosis in patients with sepsis

Value of TRIM7 in assessing the severity of the condition and determining prognosis in patients with sepsis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070123
Enrollment
Unknown
Registered
2023-04-03
Start date
2023-04-03
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Septic shock group:Standardized Treatment
sepsis group:Standardized Treatment
non-sepsis group:Standardized Treatment

Sponsors

Northern Jiangsu People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the Sepsis 3.0 diagnostic criteria issued by the American Society of Critical Care Medicine (SCCM) and the European Society of Critical Care Medicine (ESICM) in 2016 2. Age> 18 years old; 3. Newly diagnosed patients, untreated or treated with antibiotics for no more than 48 hours; 4. Completed clinical data.

Exclusion criteria

Exclusion criteria: 1. Autoimmune diseases;2. Potential immunosuppression (such as AIDS, malignant tumors in treatment, organ or bone marrow transplantation, drug-induced leukopenia);3. Pregnant women.

Design outcomes

Primary

MeasureTime frame
TRIM7 expression levels;

Secondary

MeasureTime frame
CRP levels;Lactic acid levels;procalcitonin levels;TNF-a levels;Mechanical ventilation time;Length of ICU stay;Length of stay in the hospital;28-day mortality;

Countries

China

Contacts

Public ContactMingfeng Lu

Northern Jiangsu People‘s Hospital

yzlmf2011@163.com18051062306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026